Variable Symptoms for Acid-Hydrolyzed Wheat Protein Allergy

This article originally appeared here.
Share this content:
Variable Symptoms for Acid-Hydrolyzed Wheat Protein Allergy
Variable Symptoms for Acid-Hydrolyzed Wheat Protein Allergy

THURSDAY, June 25, 2015 (HealthDay News) -- Patients with allergy to Glupearl 19S, an acid-hydrolyzed wheat protein (HWP), often manifest symptoms of HWP-wheat-dependent exercise-induced anaphylaxis and contact urticaria, according to a report published online June 20 in the International Journal of Dermatology.

Tomoko Kobayashi, M.D., from Tokyo Medical University, and colleagues describe 61 cases of patients who had used HWP-containing facial soap. After consuming wheat-containing food, 35 of these patients experienced urticaria or anaphylaxis.

The researchers found that 18 of the 35 patients with urticaria or anaphylaxis tested positive to 0.01 percent Glupearl 19S solution. In patients with versus without HWP allergy, wheat-specific immunoglobulin E (IgE) and serum gluten-specific IgE were elevated. Nine of the patients who tested positive to Glupearl 19S on the skin-prick test experienced HWP-wheat-dependent exercise-induced anaphylaxis and four experienced food-dependent anaphylaxis. Furthermore, four patients experienced worsening of symptoms during exercise in addition to food-dependent anaphylaxis.

"We found that patients with HWP allergy tended to manifest symptoms of both HWP-wheat-dependent exercise-induced anaphylaxis and contact urticaria," the authors write. "Patients with a history of these symptoms need to be informed about the risk of consuming wheat-containing foods and the importance of excluding such items from their diet."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »